QCM
GILD icon

Quest Capital Management’s Gilead Sciences GILD Stock Holding History

Quest Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$234K Sell
3,222
-9
-0.3% -$620 0.04% 282
2021
Q3 		$226K Buy
3,231
+276
+9% +$19.4K 0.04% 268
2021
Q2 		$203K Buy
+2,955
New +$197K 0.04% 277

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quest Capital Management's GILD Position: Q4 2021 in Review

Quest Capital Management reduced its Gilead Sciences (GILD) stake by 0.28% in Q4 2021, selling an estimated $620 and leaving 3,222 shares worth $234K. The position accounts for 0.04% of the portfolio, ranked #282.

Quest Capital Management first reported a position in GILD in Q2 2021 and has held it in 3 quarters since. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Quest Capital Management held 3,222 shares of Gilead Sciences worth $234K as of Q4 2021.
  • Quest Capital Management sold 9 Gilead Sciences shares in Q4 2021, an estimated $620.
  • Gilead Sciences made up 0.04% of Quest Capital Management's portfolio in Q4 2021, its #282 holding.
  • Quest Capital Management first reported a position in Gilead Sciences in Q2 2021 and has held it in 3 quarters since.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Quest Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.